NCT05641311View on ClinicalTrials.gov

Pharmacokinetic Study of Oral ALXN1840 in Japanese and Non-Japanese Adult Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 20, 2019

Primary Completion Date

May 2, 2019

Study Completion Date

May 2, 2019

Conditions
Wilson Disease
Interventions
DRUG

ALXN1840

Tablet for oral use.

Trial Locations (1)

Unknown

Richmond Pharmacology Ltd., St George's University of London, London

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY